Novel epigenetic therapies in hematological malignancies: Current status and beyond (2018)

First Author: Gallipoli P
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.12327

Publication URI: https://www.repository.cam.ac.uk/handle/1810/267479

Type: Journal Article/Review